Table 2.
Frequency of obesity, sarcopenia and sarcopenic obesity in our cohort (n = 94)
| Parameter | Median (range) | ‘Normal’ body composition (definition, n, %) | Pathological body compositions (definition, n, %) | References |
|---|---|---|---|---|
| BMI (kg/m2) | 26.0 kg/m2 (13.8–45.6) | < 30: 79 (84.0%) | > 30: 15 (16.0%) | |
| ≤ 100: 28 (29.8%) | ≥ 100: 66 (70.2%) |
Cakir et al. [17] Watanbe et al. [18] Ishi et al. [19] |
||
| VAT (cm2) | 175.1 cm2 (1.0–537.0) |
M ≤ 168/W ≤ 80: 58 (61.7%) |
M ≥ 168/W ≥ 80: 36 (38.3%) |
Van Vugt et al. [20] Doyle et al. [21] |
|
VAT/SAT: V/S ≤ 0.4: 19 (20.2%) |
VAT/SAT: V/S ≥ 0.4: 75 (79.8%) |
Clark et al. [22] Ozoya et al. [23] |
||
| Skeletal muscle mass (cm2/m2) | 51.4 cm2/m2 (32.8–79.43) |
M > 52.4/W > 38.5: 60 (63.8%) |
M ≤ 52.4/W ≤ 38.5: 34 (36.2%) |
Lieffers et al. [9] Harimoto et al. [24] Van Vugt et al. [20] Prado et al. [25] |
|
Sarcopenic obesity (VAT cm2 + SMI cm2/m2) |
n/a |
VAT ≤ 100 cm2 + SMI M > 52.4/W > 38.5: 76 (80.9%) |
VAT ≥ 100cm2 + SMI M ≤ 52.4/W ≤ 38.5: 18 (19.1%) |
Nishigori et al. [26] |